Substance Details ADB-BUTINACA - Versionsgeschichte

JennieBearden1 am 3. Juni 2026 um 07:02 Uhr

2026-06-03T07:02:29Z

XYPElissa2: Die Seite wurde neu angelegt: „In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, loco…“

2026-05-28T07:00:20Z

Die Seite wurde neu angelegt: „In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, loco…“

Neue Seite

In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc Product ions detected at m/z 302, 217, and 145 (B2) confirmed that tert-leucine and indazole moieties remained unchanged, leading to the structure elucidation of a hydroxy-functional group at the 4-position of the butyl side chain by oxidative defluorination. The product ion m/z 336 (loss of methyl ester moiety) further confirmed the presence of dihydroxylated metabolites. The precursor ion, m/z 364 (B14, B5/B6) had a loss of 2 Da from m/z 366 indicated further dehydrogenation of the ester hydrolysis plus monohydroxylated metabolites. The presence of the product ion m/z 320, likely formed from a loss of carbon dioxide, indicated monohydroxylation at the tert-leucine in B8 (m/z 219), butyl side chain in B9 (m/z 145) and indazole moiety in B13 (m/z 161). The precursor ion, m/z 350 showed a loss of 14 Da explaining the hydrolysis of methyl ester from 4F-MDMB-BINACA. Fig. 2. The precursor ion m/z 396 (B10, B12/B15) was 32 Da higher than the parent drug, 4F-MDMB-BINACA, suggesting the addition of two hydroxy groups. All the below explanations for transformations into metabolites are based on the data shown in Fig. Metabolites were identified according to their precursor ions, product ions, and fragmentation patterns (Fig. 1). Traditional in-vivo metabolism studies to generate human metabolites of drugs relied heavily on the use of whole animal model systems, which are expensive, limited by drug administration amount, influenced by species variation and faced by many ethical issues. Eight in-vivo metabolites tentatively identified were mainly products of ester hydrolysis with or without additional dehydrogenation, N-dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid. Fig. 1. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard. Fungus C. elegans Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans The % peak area abundance ratio of metabolites detected in the urine samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of drug and intake frequency), time from last drug intake and metabolic stability. This indicated that the phase I metabolism of 4F-MDMB-BINACA are unlikely to be affected significantly by polydrug intake. Oxidative defluorination with subsequent butanoic acid formation (B17) metabolite, the second major metabolite after monohydroxylation in the C. Ester hydrolysis with dehydrogenation formed in-vivo in this study was also reported among other indazole carboxamide type SCBs with tert-leucine methyl ester moieties such as 5F-MDMB-PINACA and MDMB-4en-PINACA [39, 40]. Similar to the in-vivo findings, 4F-MDMB-BINACA ester hydrolysis (B22) was the major metabolite for both HepG2 and HLM models, consistent with the known hydrolytic activity of CES reported

← Nächstältere Version		Version vom 3. Juni 2026, 07:02 Uhr
Zeile 1:		Zeile 1:
−	~~In the present study, we performed various methods based on animal behavioral testing including FOB~~ test for ~~general behavioral observation, rotarod~~ test, locomotor activity ~~test for motor function evaluation~~, ~~and water-maze test for learning/memory evaluation. Known for its stability and consistent composition~~, ~~this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study~~, ~~histopathological evaluation was performed to confirm~~ the ~~possibility of neurotoxicity~~ of the ~~tested substances by hematoxylin~~ and ~~eosin staining method from collected brain samples~~. In the ~~present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH~~-~~081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1~~, 1, ~~5 mg/kg)~~. ~~Selecting powder JWH~~-~~210 demands careful evaluation of purity~~, ~~legality~~, and ~~supplier credibility~~. ~~Prices for research-grade JWH-210 vary significantly based on quantity~~, purity, and ~~vendor complianc~~<br><br><br>~~Product ions detected at m/z 302, 217,~~ and ~~145 (B2) confirmed that tert-leucine~~ and ~~indazole moieties remained unchanged, leading to the structure elucidation of a hydroxy~~-~~functional group at the 4~~-~~position of the butyl side chain by oxidative defluorination~~. The ~~product ion m/z 336 (loss of methyl ester moiety) further confirmed~~ the ~~presence of dihydroxylated metabolites~~. ~~The precursor ion~~, m/~~z 364 (B14, B5~~/~~B6) had a loss of 2 Da from m~~/~~z 366 indicated~~ further ~~dehydrogenation~~ of the ~~ester hydrolysis plus monohydroxylated metabolites. The presence~~ of the ~~product ion m/z 320~~, ~~likely formed from~~ a ~~loss~~ of ~~carbon dioxide, indicated monohydroxylation at~~ the ~~tert-leucine~~ in ~~B8 (m/z 219)~~, ~~butyl side chain~~ in B9 (~~m/z 145~~) and ~~indazole moiety~~ in ~~B13~~ (~~m/z 161)~~. ~~The precursor ion~~, ~~m/z 350 showed a loss~~ of ~~14 Da explaining~~ the ~~hydrolysis~~ of ~~methyl ester from 4F-MDMB-BINACA.~~<br>~~Fig. 2.~~ <br>The ~~precursor ion m/z 396 (B10, B12/B15)~~ was ~~32 Da higher than~~ the ~~parent drug, 4F-MDMB-BINACA, suggesting the addition of two hydroxy groups~~. ~~All~~ the ~~below explanations for transformations into metabolites are based~~ on the ~~data shown in Fig. Metabolites~~ were ~~identified according to their precursor ions, product ions, and fragmentation patterns (Fig~~. ~~1). Traditional~~ in~~-vivo metabolism studies to generate human metabolites~~ of ~~drugs relied heavily on~~ the ~~use~~ of ~~whole animal model systems~~, ~~which are expensive~~, ~~limited by~~ drug ~~administration amount~~, ~~influenced by species variation and faced~~ by ~~many ethical issues~~. ~~Eight~~ in~~-vivo metabolites tentatively identified were mainly~~ products ~~of ester hydrolysis with~~ or ~~without additional dehydrogenation, N~~-~~dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid.~~<br>~~Fig. 1.~~ <br>~~Monitoring metabolism~~ of ~~synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus~~, ~~[https://cannabinoidsrc4f-adb~~.~~com/ 5CL ADBA powder] liver microsomes~~ and ~~confirmed using urine samples~~ The ~~threshold for fatal overdose~~ of combined ~~use~~ of SCRAs and ethanol ~~can be estimated as~~ a little ng/mL (0.37–4.1 ~~ng/mL according to the reported cases~~) of ~~SCRA~~ and 1.~~5–2~~.5 g/L ~~of ethanol. The reported cases~~ and ~~reviews~~ of the ~~scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The~~ victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [~~29, 30~~], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.<br>Fungus C. elegans <br>Methyl (~~2S)-~~2~~-([1-(4-fluorobutyl~~)~~-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (~~4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their ~~main effect~~<br><br>~~Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans~~ <br>~~The % peak area abundance ratio~~ of ~~metabolites detected in the~~ urine ~~samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of drug and intake frequency), time from last drug intake and metabolic stability~~. ~~This indicated that the phase I metabolism~~ of 4F-~~MDMB-BINACA are unlikely~~ to ~~be affected significantly by polydrug intake~~. ~~Oxidative defluorination with subsequent butanoic~~ acid ~~formation~~ (~~B17~~) ~~metabolite~~, ~~the second major metabolite after monohydroxylation in the C. Ester hydrolysis with dehydrogenation formed in~~-~~vivo in this study was also reported among other indazole carboxamide type SCBs with tert-leucine methyl ester moieties such as 5F-MDMB-PINACA~~ and ~~MDMB~~-~~4en-PINACA [39~~, ~~40]~~. ~~Similar to~~ the ~~in-vivo findings, 4F-MDMB-BINACA ester hydrolysis (B22)~~ was the ~~major metabolite for both HepG2 and HLM models, consistent with~~ the ~~known hydrolytic activity of CES reported~~	+	The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chambe<br><br><br>This makes JWH-210 powder one of the most powerful compounds in its class, often used in incense blends and research settings. Our commitment to quality and customer satisfaction makes us the best place for jwh 210 buy-whether you need it for research, incense blends, or other legal applications. For qualified professionals, investing in high-quality, verified material ensures accuracy, safety, and regulatory compliance. Prioritize vendors providing full analytical validation, transparent documentation, and compliance with international controls. Value is best assessed through consistency, verifiable purity, and regulatory compliance—not cost alon<br><br><br>Demographic and clinical features are recorded and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Second, we could not [https://cannabinoidsrc4f-adb.com/ 4F ADB] retrieve further detailed information about the e-cigarette that was used by the patient such as the label or the region of origin. Whether a recreational drug can be administered via vaping, depends on whether the drug becomes volatile under the evaporation temperature of the e-cigarette. Of these samples, 22 contained one or more SCRAs, THC was only detected in 11 samples, only one contained cannabidiol and 6 contained a mixture of THC and cannabidiol. There is difficulty in finding the right information about the NPS, defining their potency and confirmation of their existence in e-liquids or urine samples.<br>Data availabili<br><br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>The same procedure was then applied to the mice once every day for 5 days. It was considered as coordination disturbance when mice fell from the test apparatus within 2 min. Mice that remained their position on the running apparatus at 10 rpm for at least 2 min were selected for further evaluation.<br>Table of Conten<br><br><br>Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also been widely sold as a designer drug by chemical providers on the internet, first being identified in May 2020. It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug since late 2018. 4F-MDMB-BINACA (also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide famil<br><br><br>§ (3) of the Hungarian act of Forensic Experts (2016.XXIX), the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate that the simultaneous intoxication of SCRA and ethanol directly and exclusively caused the death of the two victims. The victims did not have any significant diseases that could have contributed to the outcome. Very limited data are available in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol. Several case reports describe that the presence of a little ng/mL (0.37–4.1) of SCRAs and a high—but not lethal—concentration of ethanol (1.45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2). The fact that 4F-MDMB-BINACA was not detected in postmortem urine samples is partly explained by the high rate of hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours